1-7 of 7
Niels Smedegaard Andersen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Donor Lymphocyte Infusion Is a Feasible Way to Improve Survival in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes Who Relapse after Allogeneic Stem Cell Transplantation

Lia Minculescu, Joanne Reekie, Søren Lykke Petersen, Brian Thomas Kornblit, Ida Schjødt, Niels Smedegaard Andersen, Lisbeth Pernille Andersen, Anne Fischer-Nielsen, Eva Kannik Hastrup, Lone Smidstrup Friis, Henrik Sengeloev
Journal: Blood
Blood (2021) 138 (Supplement 1): 2810.
https://doi.org/10.1182/blood-2021-148553
Published: 2021
Journal Articles

Validation of Pre-Transplantation Plasma ST2 Levels As a Prognostic Marker of 1-Year Non-Relapse Mortality after Allogeneic Hematopoietic Cell Transplantation

Lars Klingen Gjaerde, Sisse Rye Ostrowski, Frederikke Schierbeck, Niels Smedegaard Andersen, Lone Smidstrup Friis, Brian Thomas Kornblit, Søren Lykke Petersen, Ida Schjødt, Henrik Sengeloev
Journal: Blood
Blood (2021) 138 (Supplement 1): 3951.
https://doi.org/10.1182/blood-2021-144802
Published: 2021
Journal Articles

Pre-Transplantation ST2 Levels and Non-Relapse Mortality after Myeloablative Allogeneic Hematopoietic Cell Transplantation

Lars Klingen Gjærde, MD, Sisse Rye Ostrowski, MD PhD DMSc, Ass Prof, Niels Smedegaard Andersen, MD PhD DMSc, Lone Smidstrup Friis, MD PhD, Brian Kornblit, MD PhD, Søren Lykke Petersen, MD DMSc, Ida Schjødt, MD PhD, Henrik Sengeløv, MD DMSc, Prof
Journal: Blood
Blood (2020) 136 (Supplement 1): 30–31.
https://doi.org/10.1182/blood-2020-133876
Published: 2020
Journal Articles

Sirolimus Combined with Cyclosporine (CSP) and Mycophenolate Mofetil (MMF) As Graft-Vs-Host Disease (GVHD) Prophylaxis after Nonmyeloablative (NMA) Hematopoietic Cell Transplantation (HCT) Using HLA Class I or Class II Antigen Mismatched Donors: Results from a Phase II Multi-Center Trial

Brian Kornblit, MD PhD, Barry Storer, Michael B. Maris, MD, Niels Smedegaard Andersen, MD PhD, Thomas R. Chauncey, MD PhD, Effie W. Petersdorf, MD, Ann Woolfrey, MD, David G. Maloney, MD PhD, Rainer Storb, MD, Brenda M Sandmaier, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 369.
https://doi.org/10.1182/blood-2019-123196
Published: 2019
Journal Articles

Improved Relapse-Free Survival and Overall Survival in Patients with High Immune Reconstitution of Gamma Delta T Cells 2 Months after Allogeneic Hematopoietic Stem Cell Transplantation

Lia Minculescu, MD, Hanne Vibeke Marquart, MD PhD, Lars Peter Ryder, MSc, PhD, Ida Schjødt, MD PhD, Lone Smidstrup Friis, MD PhD, Brian Thomas Kornblit, MD PhD, Søren Lykke Petersen, MD DMSc., Niels Smedegaard Andersen, MD PhD, Eva Kannik Hastrup, MD PhD, Anne Fischer-Nielsen, MD PhD, Henrik Sengeloev, MD DMSc
Journal: Blood
Blood (2018) 132 (Supplement 1): 3396.
https://doi.org/10.1182/blood-2018-99-111777
Published: 2018
Journal Articles

Identification of Baseline Characteristics That Predict Good Outcome of Allogeneic Hematopoietic Cell Transplantation in Young Chronic Lymphocytic Leukemia Patients - a Retrospective Analysis from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation.

Michel van Gelder, MD PhD, Dimitris Ziagkos, Liesbeth C de Wreede, PhD, Anja van Biezen, Peter Dreger, MD, Martin Gramatzki, MD, Matthias Stelljes, Niels Smedegaard Andersen, Nicolaas PM Schaap, MD, Antonin Vitek, Dietrich Beelen, MD, Liisa Volin, MD PhD, Jürgen Finke, Jakob R Passweg, MD, Arnold Ganser, Maciej J Machaczka, MD, Julio Delgado, MD, William Krüger, Edgar Faber, Gerard Socie, Pavel Jindra, MD PhD, Boris V Afanasyev, Professor, Matthias Theobald, MD PhD, Yves Chalandon, MD, Anja Henseler, Stefan O. Schoenland, MD, Kroger Nicolaus, Johannes Schetelig, MD MSc
Journal: Blood
Blood (2016) 128 (22): 522.
https://doi.org/10.1182/blood.V128.22.522.522
Published: 2016
Journal Articles

Allogeneic Hematopoietic Transplantation in Patients with CLL: Results of a Large Disease-Specific Risk Factor Analysis

Johannes Schetelig, MD M. Sc,, Liesbeth de Wreede, Michel van Gelder, Niels Smedegaard Andersen, Carol Moreno, Antonin Vitek, Michal Karas, MD, Mauricette Michallet, MD PhD, Maciej J Machaczka, Martin Gramatzki, Dietrich Beelen, MD, Jürgen Finke, MD, Álvaro Urbano-Ispizúa, Liisa Volin, MD PhD, Jakob R. Passweg, MD, Peter Dreger, MD, Anja Henseler, Anja van Biezen, Martin Bornhäuser, MD, Stefan Schoenland, MD, Nicolaus Kröger, MD
Journal: Blood
Blood (2015) 126 (23): 3209.
https://doi.org/10.1182/blood.V126.23.3209.3209
Published: 2015